nach oben

26.04.2024 | Review

Mapping the landscape of oral cancer research trends: a systematic scientometric review of global efforts

verfasst von: Gyanajeet Yumnam, Rajkumari Sofia Devi, Charoibam Ibohal Singh

Erschienen in: Oral and Maxillofacial Surgery

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The primary goal of this study was to assess the growth, most influential articles, countries, journals, authors, and papers published in the field of global oral cancer. Research articles on oral cancer, published between 1989 and 2022, were identified through the Web of Science database to achieve this.

Methods

A comprehensive dataset comprising 7,178 documents was meticulously extracted from the Web of Science, forming the basis for scientometric analysis. A refined subset of 4,901 documents was judiciously selected following a rigorous screening process for meticulous, in-depth analysis.

Results

The field has witnessed a remarkable publication surge, with the United States taking the lead in productivity. The journal Oral Oncology has become the foremost publication, renowned for its prolific output and widespread citation. This trend highlights the growing importance and interest in this domain, with researchers and experts worldwide contributing to the expanding body of knowledge. The United States’ dominance in productivity suggests its strong commitment to advancing research in the field, while Oral Oncology’s recognition underscores its influential role in disseminating cutting-edge findings and fostering scientific progress.

Conclusion

This scientometric analysis is a valuable resource for researchers, funding agencies, industry, and institutions, offering guidance and insights.

Clinical trial number

Not Applicable.

Rivera C (2015) Essentials of oral cancer. Int J Clin Exp Pathol 8(9):11884–11894PubMedPubMedCentral

Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin 71(3):209–249. https://acsjournals.onlinelibrary.wiley.com/doi/https://doi.org/10.3322/caac.21660CrossRefPubMed

Jin LJ, Lamster IB, Greenspan JS et al (2016) Global burden of oral diseases: emerging concepts, management and interplay with systemic health. Oral Dis 22(7):609–619. https://doi.org/10.1111/odi.12428CrossRefPubMed

Gupta B, Ariyawardana A, Johnson NW (2013) Oral cancer in India continues in epidemic proportions: evidence base and policy initiatives. Int Dent J 63(1):12–25. https://doi.org/10.1111/j.1875-595x.2012.00131.xCrossRefPubMed

Purkayastha M, McMahon AD, Gibson J et al (2016) Trends of oral cavity, oropharyngeal and laryngeal cancer incidence in Scotland (1975–2012)–a socioeconomic perspective. Oral Oncol 61:70–75. https://doi.org/10.1016/j.oraloncology.2016.08.015CrossRefPubMed

Borse V, Konwar AN, Buragohain P (2020) Oral cancer diagnosis and perspectives in India. https://doi.org/10.1016/j.sintl.2020.100046. Sens Int 1

Kansy K, Mueller AA, Mücke T et al (2018) A worldwide comparison of the management of surgical treatment of advanced oral cancer. J Craniomaxillofac Surg 46(3):511–520. https://doi.org/10.1016/j.jcms.2017.12.031CrossRefPubMed

Shankar A, Roy S, Bhandari M et al (2017) Current trends in management of oral mucositis in cancer treatment. Asian Pac J Cancer Prev 18(8). https://doi.org/10.22034/apjcp.2017.18.8.2019

Santosh ABR, Jones T, Harvey J (2016) A review on oral cancer biomarkers: understanding the past and learning from the present. J Cancer Res Ther 12(2):486–492. https://doi.org/10.4103/0973-1482.176414CrossRefPubMed

10.

Petersen PE (2009) Oral cancer prevention and control-the approach of the World Health Organization. Oral Oncol 45:454–460. https://doi.org/10.1016/j.oraloncology.2008.05.023CrossRefPubMed

11.

Shield KD, Ferlay J, Jemal A et al (2017) The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012. Ca - Cancer J Clin 67:51–64. https://doi.org/10.3322/CAAC.21384CrossRefPubMed

12.

Du M, Nair R, Jamieson L et al (2020) Incidence trends of lip, oral cavity, and pharyngeal cancers: global burden of disease 1990–2017. J Dent Res 99:143–151. https://doi.org/10.1177/0022034519894963CrossRefPubMed

13.

Gyanajeet Y, Ibohal Singh C (2023) A scientometric visualization of 32 years of leukemia research in India. Sci Technol Libr 1–19. https://doi.org/10.1080/0194262X.2023.2181279

14.

Gyanendra Y, Yumnam G, Alam W et al (2022) A bibliometric analysis and assessment of scientific studies trend on groundwater research in India during 1989–2020. Arab J Geosci 15(16):1417. https://doi.org/10.1007/s12517-022-10707-0CrossRef

15.

Liu W, Wu L, Zhang Y et al (2020) Bibliometric analysis of research trends and characteristics of oral potentially malignant disorders. Clin Oral Invest 24:447–454. https://doi.org/10.1007/s00784-019-02959-0CrossRef

16.

Ma L, Gao X, Liu W (2020) Bibliometric analysis of the top-100 cited articles on oral potentially malignant disorders to guide research topic and direction. J Dent Sci 15(4):479–485. https://doi.org/10.1016/j.jds.2019.09.011CrossRefPubMed

17.

Sharifi A, Simangan D, Kaneko S (2021) Three decades of research on climate change and peace: a bibliometrics analysis. Sustain Sci 16:1079–1095. https://doi.org/10.1007/s11625-020-00853-3CrossRef

18.

Aria M, Cuccurullo C (2017) Bibliometrix: an R-tool for comprehensive science mapping analysis. J Informetr 11(4):959–975. https://doi.org/10.1016/j.joi.2017.08.007CrossRef

19.

van Eck NJ, Waltman L (2010) Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics 84(2):523–538. https://doi.org/10.1007/s11192-009-0146-3CrossRefPubMed

20.

Garfield E (2009) From the science of science to scientometrics visualizing the history of science with Histcite Software. J Informetr 3(3):173–179. https://doi.org/10.1016/j.joi.2009.03.009CrossRef

21.

Persson O, Danell R, Schneider JW (2009) How to use BibExcel for various types of bibliometric analysis. Celebrating scholarly communication studies: a festschrift for Olle Persson at his 60th Birthday 5:9–24

22.

Su SY, Chen WT, Chiang CJ et al (2020) Oral cancer incidence rates from 1997 to 2016 among men in Taiwan: association between birth cohort trends and betel nut consumption. Oral Oncol 107:104798. https://doi.org/10.1016/j.oraloncology.2020.104798CrossRefPubMed

23.

Jhuang JR, Su SY, Chiang CJ et al (2022) Forecast of peak attainment and imminent decline after 2017 of oral cancer incidence in men in Taiwan. Sci Rep 12(1). https://doi.org/10.1038/s41598-022-09736-2

24.

Saidak Z, Lailler C, Testelin S et al (2021) Contribution of genomics to the surgical management and study of oral cancer. Ann Surg Onco 28(11):5842–5854. https://doi.org/10.1245/s10434-021-09904-0CrossRef

25.

Fu HZ, Chuang KY, Wang MH et al (2011) Characteristics of research in China assessed with essential science indicators. Scientometrics 88(3):841–862. https://doi.org/10.1007/s11192-011-0416-8CrossRef

26.

El-Sayed IH, Huang X, El-Sayed MA (2005) Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer. Nano Lett 5(5):829–834. https://doi.org/10.1021/nl050074eCrossRefPubMed

27.

Herrero R, Castellsagué X, Pawlita M et al (2003) Human papillomavirus and oral cancer: the international agency for research on cancer multicenter study. J Natl Cancer Inst 95(23):1772–1783. https://doi.org/10.1093/jnci/djg107CrossRefPubMed

28.

Neville BW, Day TA (2002) Oral cancer and precancerous lesions. CA: Cancer J Clin 52(4):195–215. https://doi.org/10.3322/canjclin.52.4.195CrossRefPubMed

29.

D’Cruz AK, Vaish R, Kapre N et al (2015) Elective versus therapeutic neck dissection in node-negative oral cancer. N Engl J Med 373(6):521–529. https://doi.org/10.1056/NEJMoa1506007CrossRefPubMed

30.

Ko YC, Huang YL, Lee CH et al (1995) Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med 24(10):450–453. https://doi.org/10.1111/j.1600-0714.1995.tb01132.xCrossRefPubMed

31.

Park NJ, Zhou H, Elashoff D et al (2009) Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection salivary microRNA. Clin Cancer Res 15(17):5473–5477. https://doi.org/10.1158/1078-0432.CCR-09-0736CrossRefPubMedPubMedCentral

32.

Chiou S-H, Yu C-C, Huang C-Y et al (2008) Positive correlations of Oct-4 and nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res 14(13):4085–4095. https://doi.org/10.1158/1078-0432.ccr-07-4404CrossRefPubMed

33.

Kozaki KI, Imoto I, Mogi S et al (2008) Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res 68(7):2094–2105. https://doi.org/10.1158/0008-5472.can-07-5194CrossRefPubMed

34.

Shah JP, Gil Z (2009) Current concepts in management of oral cancer–surgery. Oral Oncol 45(4–5):394–401. https://doi.org/10.1016/j.oraloncology.2008.05.017CrossRefPubMed

35.

Sankaranarayanan R, Ramadas K, Thomas G et al (2005) Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial. Lancet 365(9475):1927–1933. https://doi.org/10.1016/S0140-6736(05)66658-5CrossRefPubMed

36.

Song Y, Chen X, Hao T et al (2019) Exploring two decades of research on classroom dialogue by using bibliometric analysis. Comput Educ 137:12–31. https://doi.org/10.1016/j.compedu.2019.04.002CrossRef

37.

Warnakulasuriya S, Sutherland G, Scully C (2005) Tobacco, oral cancer, and treatment of dependence. Oral Oncol 41(3):244–260. https://doi.org/10.1016/j.oraloncology.2004.08.010CrossRefPubMed

38.

Johnson N (2001) Tobacco use and oral cancer: a global perspective. J Dent Educ 65(4):328–339. https://doi.org/10.1002/j.0022-0337.2001.65.4.tb03403.xCrossRefPubMed

39.

Zhuo W, Wang Y, Zhuo X et al (2009) CYP1A1 and GSTM1 polymorphisms and oral cancer risk: association studies via evidence-based meta-analyses. Cancer Investig 27(1):86–95. https://doi.org/10.1080/07357900802146170CrossRef

40.

Li Y, St John MA, Zhou X et al (2004) Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res 10(24):8442–8450. https://doi.org/10.1158/1078-0432.CCR-04-1167CrossRefPubMed

41.

Cruz GD, Le Geros RZ, Ostroff JS et al (2002) Oral cancer knowledge, risk factors and characteristics of subjects in a large oral cancer screening program. J Am Dent Assoc 133(8):1064–1071. https://doi.org/10.14219/jada.archive.2002.0330CrossRefPubMed

42.

Kok SH, Cheng SJ, Hong CY et al (2005) Norcantharidin-induced apoptosis in oral cancer cells is associated with an increase of proapoptotic to antiapoptotic protein ratio. Cancer Lett 217(1):43–52. https://doi.org/10.1016/j.canlet.2004.07.045CrossRefPubMed

43.

Divaris K, Olshan AF, Smith J et al (2010) Oral health and risk for head and neck squamous cell carcinoma: the Carolina head and neck cancer study. Cancer Causes Control 21:567–575. https://doi.org/10.1007/s10552-009-9486-9CrossRefPubMedPubMedCentral

44.

Da Silva SD, Alaoui-Jamali MA, Soares FA et al (2014) TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic target. Cancer 120(3):352–362. https://doi.org/10.1002/cncr.28404CrossRefPubMed

45.

Su S, Chien M, Lin C et al (2015) RAGE gene polymorphism and environmental factor in the risk of oral cancer. J Dent Res 94(3):403–411. https://doi.org/10.1177/0022034514566215CrossRefPubMedPubMedCentral

46.

More CB, Das S, Patel H et al (2012) Proposed clinical classification for oral submucous fibrosis. Oral Oncol 48(3):200–202. https://doi.org/10.1016/j.oraloncology.2011.10.011CrossRefPubMed

47.

Lim HJ, Oh CH (2011) Indocyanine green-based photodynamic therapy with 785 nm light emitting diode for oral squamous cancer cells. Photodiagnosis Photodyn Ther 8(4):337–342. https://doi.org/10.1016/j.pdpdt.2011.06.002CrossRefPubMed

48.

Nayak PP, Nayak SS, Sathiyabalan D et al (2018) Assessing the feasibility and effectiveness of an app in improving knowledge on oral cancer—an interventional study. J Canc Educ 33:1250–1254. https://doi.org/10.1007/s13187-017-1239-yCrossRef

49.

Patil VM, Noronha V, Joshi A et al (2020) Beyond conventional chemotherapy, targeted therapy and immunotherapy in squamous cell cancer of the oral cavity. Oral Oncol 105:104673. https://doi.org/10.1016/j.oraloncology.2020.104673CrossRefPubMed

50.

Klingelhöffer C, Obst A, Ettl T et al (2019) Severe postoperative dysphagia as an early predictor for decreased overall survival in patients with oral cancer. J Maxillofac Surg 47(9):1363–1369. https://doi.org/10.1016/j.jcms.2019.06.011CrossRef

51.

Nulent TJK, Noorlag R, Van Cann EM et al (2018) Intraoral ultrasonography to measure tumor thickness of oral cancer: a systematic review and meta-analysis. Oral Oncol 77:29–36. https://doi.org/10.1016/j.oraloncology.2017.12.007CrossRef

52.

Zhang Y, Cui C, Wang Y et al (2020) Effects of stigma, hope and social support on quality of life among Chinese patients diagnosed with oral cancer: a cross-sectional study. Health Qual Life Outcomes 18:1–8. https://doi.org/10.1186/s12955-020-01353-9CrossRef

53.

Manyanga J, Ganapathy V, Bouharati C et al (2021) Electronic cigarette aerosols alter the expression of cisplatin transporters and increase drug resistance in oral cancer cells. Sci Rep 11(1):1821. https://doi.org/10.1038/s41598-021-81148-0CrossRefPubMedPubMedCentral

54.

Yan M, Ouyang Q, Sun T et al (2022) Pyrotinib plus capecitabine for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases (PERMEATE): a multicentre, single-arm, two-cohort, phase 2 trial. Lancet Oncol 23(3):353–361. https://doi.org/10.1016/S1470-2045(21)00716-6CrossRefPubMed

55.

Baby NT, Abdullah A, Kannan S (2022) The scope of liquid biopsy in the clinical management of oral cancer. Int J Oral Maxillofac Surg 51(5):591–601. https://doi.org/10.1016/j.ijom.2021.08.017CrossRefPubMed

56.

Vuity D, McMahon J, Hislop S et al (2022) Sentinel lymph node biopsy for early oral cancer–accuracy and considerations in patient selection. Br J Oral Maxillofac Surg 60(6):830–836. https://doi.org/10.1016/j.bjoms.2021.12.058CrossRefPubMed

57.

Ashrafizadeh M, Zarrabi A, Orouei S et al (2021) MicroRNA-mediated autophagy regulation in cancer therapy: the role in chemoresistance/chemosensitivity. Eur J Pharmacol 892:173660. https://doi.org/10.1016/j.ejphar.2020.173660CrossRefPubMed

58.

Amrati FEZ, Elmadbouh OHM, Chebaibi M et al (2022) Evaluation of the toxicity of Caralluma europaea (CE) extracts and their effects on apoptosis and chemoresistance in pancreatic cancer cells. J Biomol Struct Dyn 1–18. https://doi.org/10.1080/07391102.2022.2135595

59.

Shuaib W, Khan MS, Shahid H et al (2015) Bibliometric analysis of the top 100 cited cardiovascular articles. Am J Cardiol 115(7):972–981. https://doi.org/10.1016/j.amjcard.2015.01.029CrossRefPubMed

60.

Fardi A, Kodonas K, Gogos C et al (2011) Top cited articles in endodontic journals. J Endod 37(9):1183–1190. https://doi.org/10.1016/j.joen.2011.05.037CrossRefPubMed

61.

Foy JP, Bertolus C, Goudot P et al (2018) Bibliometric analysis of a century of research on oral erythroplakia and leukoplakia. J Oral Pathol Med 47(4):388–395. https://doi.org/10.1111/jop.12683CrossRefPubMed

62.

Shamszadeh S, Asgary S, Nosrat A (2019) Regenerative endodontics: a scientometric and bibliometric analysis. J Endod 45(3). https://doi.org/10.1016/j.joen.2018.11.010

63.

Singh AK, Singh RP, Dipak S (2023) Current trends and themes of oral cancer research: a bibliometric analysis of publications from 2011 to 2022 in prominent oral pathology-related journals. Oral Oncol Rep 6. https://doi.org/10.1016/j.oor.2023.100037

64.

Liz J, Esteller M (2016) lncRNAs and microRNAs with a role in cancer development. Biochim Biophys Acta Gene Regul Mech BBA-Gene Regul Mech 1859(1):169–176. https://doi.org/10.1016/j.bbagrm.2015.06.015CrossRef

65.

Gomes CC, Gomez RS (2008) MicroRNA and oral cancer: future perspectives. Oral Oncol 44(10):910–914. https://doi.org/10.1016/j.oraloncology.2008.01.002CrossRefPubMed

66.

Mc Y, Hs W, Yang X et al (2022) A bibliometric analysis and visualization of current research trends in Chinese medicine for osteosarcoma. Chin J Integr Med 28:445–452. https://doi.org/10.1007/s11655-020-3429-4CrossRef

67.

Hirasawa T, Ikenoyama Y, Ishioka M et al (2020) Current status and future perspective of artificial intelligence applications in endoscopic diagnosis and management of gastric cancer. Dig Endosc 33(2):263–272. https://doi.org/10.1111/den.13890CrossRefPubMed

68.

Hosny A, Parmar C, Quackenbush J et al (2018) Artificial intelligence in radiology. Nat Rev Cancer 18(8):500–510. https://doi.org/10.1038/s41568-018-0016-5CrossRefPubMedPubMedCentral

69.

Tobias MAS, Nogueira BP, Santana MCS et al (2022) Artificial intelligence for oral cancer diagnosis: what are the possibilities? Oral Oncol 134:106117. https://doi.org/10.1016/j.oraloncology.2022.106117CrossRefPubMed

70.

Adeoye J, Tan JY, Choi S-W et al (2021) Prediction models applying machine learning to oral cavity cancer outcomes: a systematic review. Int J Med Inf 154:104557. https://doi.org/10.1016/j.ijmedinf.2021.104557CrossRef

71.

Kar A, Wreesmann VB, Shwetha V et al (2020) Improvement of oral cancer screening quality and reach: the promise of artificial intelligence. J Oral Pathol Med 49(8):727–730. https://doi.org/10.1111/jop.13013CrossRefPubMed

72.

Kim DW, Lee S, Kwon S et al (2019) Deep learning-based survival prediction of oral cancer patients. Sci Rep 9(1):1–10. https://doi.org/10.1038/s41598-019-43372-7CrossRef

Titel: Mapping the landscape of oral cancer research trends: a systematic scientometric review of global efforts
verfasst von: Gyanajeet Yumnam
Rajkumari Sofia Devi
Charoibam Ibohal Singh
Publikationsdatum: 26.04.2024
Verlag: Springer Berlin Heidelberg
Erschienen in: Oral and Maxillofacial Surgery
Print ISSN: 1865-1550
Elektronische ISSN: 1865-1569
DOI: https://doi.org/10.1007/s10006-024-01253-y

Neu im Fachgebiet Chirurgie

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Clinical trial number

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Update Chirurgie